Live news related to MEDINCELL stock (FR0004065605): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The Montpellier-based biotech regains momentum mid-morning, following a sharp drop after the release of its annual financial statements. The stock is …
The biotech company from Montpellier opens the session with heavy penalties. The stock collapses as the annual results show a significant deepening of…
Medincell continues its pivot towards recurring revenue: royalties from its first commercialized product, Uzedy (risperidone), have surged by 42% to €…
The biotech company from Montpellier is moving forward on the eve of its annual financial report. The stock is among the top performers in the SBF 120…
The biotech company from Montpellier experiences a sharp decline mid-session, going against its recent momentum. The stock struggles at the bottom of …
The biotech company from Montpellier advances in mid-morning trading, bucking the trend of a Parisian market weighed down by inflationary fears linked…
The biotech company from Montpellier continues its recovery in late morning trading, in a Parisian market trending upwards. The stock benefits from ne…
The biotech company from Montpellier turns positive in early afternoon, going against its decline from the previous day. This movement follows a favor…
The biotech company based in Montpellier continues its decline at midday, in a Parisian market that is also trending downward. This movement occurs as…
The biotech company from Montpellier faces a tough session at midday, moving against the trend of a well-oriented Parisian market. The stock is among …
